Abstract
In the September issue of this journal, performance of BinaxNOW for the diagnosis of malaria in a major U.S. academic medical center was reported ([1][1]). Herein, we report performance of this test in a second large academic medical center in the United States. BinaxNOW was introduced at our
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
